| China In Vitro Diagnostics Investment Opportunities, | | | | process, pricing trends and reimbursement. |
| Analysis and Forecasts to 2015 | | | | Product and brand updates, strategy changes, |
| Summary | | | | R&D projects, corporate expansions and |
| This report is an essential source for in-depth | | | | contractions and regulatory changes. |
| information and data relating to China In vitro diagnostic | | | | Key mergers and acquisitions, partnerships, private |
| dvices market. It also offers detailed and | | | | equity investments and IPOs. |
| comprehensive coverage of market revenue, | | | | Customer, hospitals and physicians data. 1 Table of |
| distribution and company share information; and the | | | | Contents |
| latest news, financial deals and pipeline products | | | | 1.1 List of Tables |
| information of each of the key sub-segments of the in | | | | 1.2 List of Figures 2 Introduction |
| vitro diagnostics market in China | | | | 2.1 What Is This Report About? 3 Definitions of |
| Scope | | | | Markets Covered in This Report |
| The report provides information on the Chinese in vitro | | | | 3.1 In Vitro Diagnostics |
| diagnostics market, broken down into detailed | | | | 3.2 Clinical Chemistry |
| categories and segments including In Vitro Diagnostics | | | | 3.3 Genetic Testing |
| Devices, Clinical Chemistry Test Reagents, | | | | 3.4 Haematology |
| Immunochemistry Test Reagents, Blood Test | | | | 3.5 Histology And Cytology |
| Reagents, Microbiology Test Reagents, Infectious | | | | 3.6 Immuno Chemistry |
| Immunology Test Reagents, Genetic Test Reagents, | | | | 3.7 Infectious Immunology |
| Self Testing, and Instruments. | | | | 3.8 Microbiology Culture 4 Healthcare Sector Review |
| Market shares of all the key competitors including F. | | | | 4.1 Healthcare Expenditure |
| Hoffmann-La Roche Ltd., Abbott Laboratories, | | | | 4.2 Healthcare Infrastructure |
| Beckman Coulter, Inc., and Siemens Medical Solutions, | | | | 4.3 Healthcare Policy 5 Regulation System |
| amongst others. | | | | 5.1 Medical Equipment Approval Process |
| Key pipeline products that are set to shape the | | | | 5.2 Post Market Surveillance (PMS) 6 Pricing and |
| market, broken down by sector. | | | | Reimbursement 7 Distribution Structure 8 In Vitro |
| Information on the top medical equipment companies in | | | | Diagnostics In China |
| the sector in the country covering business description, | | | | 8.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), |
| strategic analysis. | | | | 2000-2015 |
| Healthcare structure, regulatory environment, approval | | | | 8. |